Addressing Loss-of-Efficacy in Permanently-Implanted SCS-Patients: Therapy Salvage Using Standardized Connections or Adapters

Thursday, November 13, 2025

9:11 AM - 9:19 AM CT

Location: 301 - 302

Introduction: The Institute of Neuromodulation (loN) advocates for standardized connector designs for neuromodulation devices to help address certain complications, including Loss of Efficacy (LoE) in permanently-implanted Spinal Cord Stimulation (SCS) patients.¹Although data from patients using SCS devices from different manufacturers with standardized IPGs (not requiring adaptors) has been reported, use of noncompatible leads/lPGs require FDA-approved adaptors.² A recent study utilizing such adaptors in patients experiencing LoE reported a high rate (-60%) of therapy salvage.³

Presenting Author(s)

NH

Namath Hussain, MD

Pain Management Physician
Loma Linda University Faculty Medical Clinics, United States

Co-Author(s)

EG

Ewan Gillespie, MBA

Director, Medical Affairs
Boston Scientific, United States
RS

Rajat Shivacharan, PhD

Principal Clinical Scientist
Boston Scientific, United States

Submitting Author(s)

EG

Edward Goldberg, MD

Director, Clinical Research
Boston Scientific
Valencia, California, United States